Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?
- PMID: 15980997
- DOI: 10.1007/s10549-005-1942-y
Lamivudine therapy in HBsAg-carrying breast cancer patients undergoing chemotherapy: prophylactic or preemptive?
Comment on
-
Use of lamivudine to prevent hepatitis B virus reactivation during chemotherapy in breast cancer patients.Breast Cancer Res Treat. 2004 Dec;88(3):209-15. doi: 10.1007/s10549-004-0725-1. Breast Cancer Res Treat. 2004. PMID: 15609123
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
